Weeks 3 to 10: Insurance processing and medication delivery If your medication requires prior authorization, Calibrates Insurance Navigation Team handles it for you
(average results) Wegovy (semaglutide) GLP-1 only In the STEP-1 study (68 weeks), average weight change was about: 14.9% with Wegovy 2.4% with placebo (dummy injection) What that looks like: If you start at 100 kg , 14.9% is about 15 kg lost on average
If youre pregnant, breastfeeding, on medication, or have a medical condition, make sure to discuss this with your doctor first
In line with BSSM guidance and testosterone SmPCs (e.g., Nebido), TRT should be paused or the dose reviewed if haematocrit exceeds 0.54
Combined therapeutic strategy of GLP-1RAs and antidiabetic medications The combination of SGLT2 inhibitors or thiazolidinediones with GLP-1RAs has been shown to significantly enhance therapeutic efficacy against liver cancer
Tirzepatide (Zepbound) produces 22.5%, and semaglutide (Wegovy) produces 14.9%